Skip to main navigation Skip to search Skip to main content

Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science